The Unplugged program in Chile ("Yo Sé Lo Que Quiero") for substance use prevention among early adolescents: study protocol for a randomized controlled trial

Jorge Gaete, Saray Ramírez, Sofía Gana, Daniela Valenzuela, Ricardo Araya, Jorge Gaete, Saray Ramírez, Sofía Gana, Daniela Valenzuela, Ricardo Araya

Abstract

Background: Substance use is among the main contributors to disease among children and adolescents in the Americas region. The call for effective prevention of substance use among adolescents has resulted in numerous school-based programs, and particularly the Unplugged program has been proved to be successful in reducing the prevalence of different substances in seven European countries. The purpose of this study is to test the effectiveness of the Unplugged program in Chile ("Yo Sé Lo Que Quiero").

Methods: This is a cluster randomized controlled trial, parallel-group type, where "Yo Sé Lo Que Quiero" is compared to standard school preventive curricula in control schools. A total of 70 schools and 8400 adolescents are expected to be randomized with 1:1 allocation. During formative work, the Unplugged program was culturally adapted to Chile, and the instrument to assess the primary and secondary outcomes was validated. The effectiveness of this program will be assessed using the European Drug Addiction Prevention Trial Questionnaire (EU-Dap), measuring substance use prevalence and risk and protective factors in baseline, post-intervention, and four months after the end of the intervention.

Discussion: The proposed study will be the first to test the effectiveness of a school-based substance use prevention program in Chile in a cluster randomized control trial and the first study evaluating the Unplugged program in Spanish-speaking Latin America. A model for disseminating the Unplugged program inside Europe already exists and has been implemented successfully in several countries. Thus, if the effects of the program are positive, wide implementation in Chile and Latin American countries is possible soon.

Trial registration: ClinicalTrials.gov NCT04236999 . Registered on January 17, 2020.

Keywords: Adolescents; Prevention; Randomized control trial; Schools; Substance use.

Conflict of interest statement

The authors declare that they have no competing interests.

© 2022. The Author(s).

References

    1. Kohn R, Ali AA, Puac-Polanco V, Figueroa C, López-Soto V, Morgan K, Saldivia S, Vicente B. Mental health in the Americas: an overview of the treatment gap. Rev Panam Salud Publica. 2018;42:e165. doi: 10.26633/RPSP.2018.165.
    1. Hynes M, Clarke P, Cumsille F, Araneda J, Ahumada G. Informe sobre el consumo de drogas en las Américas 2019. 2019.
    1. Servicio Nacional para la Prevención y Rehabilitación del Consumo de Drogas y Alcohol(SENDA). Décimo Tercer Estudio Nacional de drogas en población escolar de Chile, 2019 [Internet]. Santiago Chile: Observatorio Chileno de Drogas; 2020 [cited 2021 May 11]. Available from: .
    1. Thorisdottir IE, Asgeirsdottir BB, Kristjansson AL, Valdimarsdottir HB, Tolgyes EM, Sigfusson J, et al. Depressive symptoms, mental wellbeing, and substance use among adolescents before and during the COVID-19 pandemic in Iceland: a longitudinal, population-based study. Lancet Psychiatry. 2021;8(8):663–72. 10.1016/S2215-0366(21)00156-5.
    1. Esmaeelzadeh S, Moraros J, Thorpe L, Bird Y. The association between depression, anxiety and substance use among Canadian post-secondary students. Neuropsychiatr Dis Treat. 2018;14:3241–3251. doi: 10.2147/NDT.S187419.
    1. Hall WD, Patton G, Stockings E, Weier M, Lynskey M, Morley KI, Degenhardt L. Why young people's substance use matters for global health. Lancet Psychiatry. 2016;3(3):265–279. doi: 10.1016/S2215-0366(16)00013-4.
    1. Davidson LL, Grigorenko EL, Boivin MJ, Rapa E, Stein A. A focus on adolescence to reduce neurological, mental health and substance-use disability. Nature. 2015;527(7578):S161–S166. doi: 10.1038/nature16030.
    1. Degenhardt L, Stockings E, Patton G, Hall WD, Lynskey M. The increasing global health priority of substance use in young people. Lancet Psychiatry. 2016;3(3):251–264. doi: 10.1016/S2215-0366(15)00508-8.
    1. Hong SA, Peltzer K. Early Adolescent Patterns of Alcohol and Tobacco Use in Eight Association of South-East Asian Nations (ASEAN) Member States. Subst Use Misuse. 2019;54(2):288–296. doi: 10.1080/10826084.2018.1517797.
    1. Lebel C, Beaulieu C. Longitudinal development of human brain wiring continues from childhood into adulthood. J Neurosci. 2011;31(30):10937–10947. doi: 10.1523/JNEUROSCI.5302-10.2011.
    1. Meruelo AD, Castro N, Cota CI, Tapert SF. Cannabis and alcohol use, and the developing brain. Behav Brain Res. 2017;325(Pt A):44–50. doi: 10.1016/j.bbr.2017.02.025.
    1. Squeglia LM, Gray KM. Alcohol and drug use and the developing brain. Curr Psychiatry Rep. 2016;18(5):46. doi: 10.1007/s11920-016-0689-y.
    1. Wetherill R, Tapert SF. Adolescent brain development, substance use, and psychotherapeutic change. Psychol Addict Behav. 2013;27(2):393–402. doi: 10.1037/a0029111.
    1. Faggiano F, Minozzi S, Versino E, Buscemi D. Universal school-based prevention for illicit drug use. Cochrane Database Syst Rev. 2014;2014(12):Cd003020.
    1. Lize SE, Iachini AL, Tang W, Tucker J, Seay KD, Clone S, DeHart D, Browne T. A meta-analysis of the effectiveness of interactive middle school cannabis prevention programs. Prev Sci. 2017;18(1):50–60. doi: 10.1007/s11121-016-0723-7.
    1. Agabio R, Trincas G, Floris F, Mura G, Sancassiani F, Angermeyer MC. A Systematic review of school-based alcohol and other drug prevention programs. Clin Pract Epidemiol Ment Health. 2015;11(Suppl 1 M6):102–112. doi: 10.2174/1745017901511010102.
    1. Faggiano F, Vigna-Taglianti F, Burkhart G, Bohrn K, Cuomo L, Gregori D, Panella M, Scatigna M, Siliquini R, Varona L, van der Kreeft P, Vassara M, Wiborg G, Galanti MR, EU-Dap Study Group The effectiveness of a school-based substance abuse prevention program: 18-month follow-up of the EU-Dap cluster randomized controlled trial. Drug Alcohol Depend. 2010;108(1-2):56–64. doi: 10.1016/j.drugalcdep.2009.11.018.
    1. Servicio Nacional para la Prevención y Rehabilitación del Consumo de Drogas y Alcohol (SENDA). Elige Vivir Sin Drogas [Internet]. Santiago Chile: Gobierno de Chile; 2019 [cited 2021 May 11]. Available from:
    1. Corea ML, Zubarew T, Valenzuela MT, Salas F. Evaluación del programa “Familias fuertes: amor y límites” en familias con adolescentes de 10 a 14 años. Rev Méd Chil. 2012;140(6):726–731. doi: 10.4067/S0034-98872012000600005.
    1. Faggiano F, Richardson C, Bohrn K, Galanti MR. A cluster randomized controlled trial of school-based prevention of tobacco, alcohol and drug use: the EU-Dap design and study population. Prev Med. 2007;44(2):170–173. doi: 10.1016/j.ypmed.2006.09.010.
    1. Caria MP, Faggiano F, Bellocco R, Galanti MR, Group E-DS Effects of a school-based prevention program on European adolescents' patterns of alcohol use. J Adolesc Health. 2011;48(2):182–188. doi: 10.1016/j.jadohealth.2010.06.003.
    1. Vigna-Taglianti FD, Galanti MR, Burkhart G, Caria MP, Vadrucci S, Faggiano F. “Unplugged,” a European school-based program for substance use prevention among adolescents: overview of results from the EU-Dap trial. New Dir Youth Dev. 2014;2014(141):67–82. doi: 10.1002/yd.20087.
    1. Brigham GS, Feaster DJ, Wakim PG, Dempsey CL. Choosing a control group in effectiveness trials of behavioral drug abuse treatments. J Subst Abuse Treat. 2009;37(4):388–397. doi: 10.1016/j.jsat.2009.05.004.
    1. Junta Nacional de Auxilio Escolar y Becas Dirección Nacional. SINAE Sistema Nacional de Asignación con Equidad para Becas JUNAEB [Internet]. Santiago Chile: Gobierno de Chile; 2005 [cited 2021 May 11]. Available from:
    1. U.S. Food & Drug Administration. Regulations. Good Clinical Practice and Clinical Trials [Internet]. [Washington D.C. The United States: United States Government]; 2021 [cited 2021 May 11]. Available from:

Source: PubMed

Sponsors and Collaborators

Medical Conditions

Drug Interventions

3
Subscribe